BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15048623)

  • 1. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
    Zuccari DA; Santana AE; Cury PM; Cordeiro JA
    Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors.
    Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS
    J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic examination of fine-needle aspirates from mammary gland tumors in the dog: diagnostic accuracy with comparison to histopathology and association with postoperative outcome.
    Simon D; Schoenrock D; Nolte I; Baumgärtner W; Barron R; Mischke R
    Vet Clin Pathol; 2009 Dec; 38(4):521-8. PubMed ID: 19392751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
    Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
    Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
    Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Ki-67 proliferation marker in the cytologic identification of liver tumors in dogs.
    Neumann S; Kaup FJ
    Vet Clin Pathol; 2005 Jun; 34(2):132-6. PubMed ID: 15902664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
    Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
    Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance.
    Nieto A; Peña L; Pérez-Alenza MD; Sánchez MA; Flores JM; Castaño M
    Vet Pathol; 2000 May; 37(3):239-47. PubMed ID: 10810988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
    Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
    Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
    Löhr CV; Teifke JP; Failing K; Weiss E
    Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractal dimension of canine mammary gland epithelial tumors on cytologic smears.
    Simeonov R; Simeonova G
    Vet Clin Pathol; 2006 Dec; 35(4):446-8. PubMed ID: 17123252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
    Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
    Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
    Chung H; Lee S; Kim GA; Kim WH
    PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
    Geraldes M; Gärtner F; Schmitt F
    Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002).
    Chang SC; Chang CC; Chang TJ; Wong ML
    J Am Vet Med Assoc; 2005 Nov; 227(10):1625-9. PubMed ID: 16313041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.